Strongbridge Bio Ord
(SBBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,055 | -11,814 | -45,075 | -33,129 | -29,970 |
| Depreciation Amortization | 2,554 | 1,277 | 5,107 | 3,830 | 2,554 |
| Accounts receivable | -780 | -45 | -512 | -606 | -596 |
| Accounts payable and accrued liabilities | -848 | 4,256 | -1,848 | -1,743 | -1,374 |
| Other Working Capital | -5,769 | -6,192 | -7,022 | -9,620 | -10,217 |
| Other Operating Activity | 6,678 | -875 | 11,216 | 8,134 | 12,228 |
| Operating Cash Flow | $-23,220 | $-13,393 | $-38,134 | $-33,134 | $-27,375 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 21,122 | 21,122 | 21,122 |
| PPE Investments | -10 | -10 | -10 | -10 | N/A |
| Investing Cash Flow | $-10 | $-10 | $21,112 | $21,112 | $21,122 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 19,325 | 9,325 | 9,460 |
| Common Stock Issued | 176 | 176 | 28,601 | 27,872 | N/A |
| Other Financing Activity | -694 | -397 | -414 | -414 | -330 |
| Financing Cash Flow | $-518 | $-221 | $47,512 | $36,783 | $9,130 |
| Beginning Cash Position | 87,522 | 87,522 | 57,032 | 57,032 | 57,032 |
| End Cash Position | 63,774 | 73,898 | 87,522 | 81,793 | 59,909 |
| Net Cash Flow | $-23,748 | $-13,624 | $30,490 | $24,761 | $2,877 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,220 | -13,393 | -38,134 | -33,134 | -27,375 |
| Capital Expenditure | -10 | -10 | -10 | -10 | N/A |
| Free Cash Flow | -23,230 | -13,403 | -38,144 | -33,144 | -27,375 |